TC
ALDR

TFS Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

TFS Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-15,354
Closed -$503K – 1010
2015
Q3 		$503K Sell
15,354
-4,063
-21% -$173K 0.05% 522
2015
Q2 		$1.03M Sell
19,417
-47,264
-71% -$1.72M 0.1% 327
2015
Q1 		$1.92M Buy
66,681
+22,176
+50% +$609K 0.19% 148
2014
Q4 		$1.29M Buy
44,505
+22,033
+98% +$395K 0.12% 254
2014
Q3 		$285K Buy
+22,472
New +$340K 0.02% 759

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

TFS Capital's ALDR Position: Q4 2015 in Review

TFS Capital sold out of Alder Biopharmaceuticals (ALDR) in Q4 2015, closing a stake of 15,354 shares — an estimated $503K sold.

TFS Capital first reported a position in ALDR in Q3 2014 and held it in 5 quarters. The position peaked at $1.92M in Q1 2015. 134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • TFS Capital reported no remaining Alder Biopharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 15,354 Alder Biopharmaceuticals shares in Q4 2015, an estimated $503K.
  • TFS Capital first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 5 quarters.
  • TFS Capital's Alder Biopharmaceuticals position peaked at $1.92M in Q1 2015.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.